Published on December 27th, 2016 | by Malin Anderson0
6-7 March 2017: Biologics & Biosimilars Congress
The 3rd Biologics & Biosimilars Congress examines scientific and technological trends to advance protein and antibody therapeutics.
The congress 2017 will feature new extended panel discussions with senior executives from prominent organisations. Drawing on their experience and insights these leaders will discuss the challenges, opportunities and future direction of a range promising research fields. The panels will cover themes such as ‘advancing immunotherapy’, ‘ADCs: Design and optimisation’ and ‘Biosimilars: Communication and Awareness’.
In addition round table discussions will offer attendees the opportunity to discuss important topics in the field of Biosimilars. Focusing on regulation, public perception and development issues; the conversation will be facilitated by leaders in the respective fields and enable further exploration of themes raised in the conference agenda.
As well as providing ample opportunity for you to ask questions of the panellists, there are over 6 hours of networking time allocated throughout the congress, including the drinks reception at the end of day one. This will help you make the most of the opportunity to talk further with the 60 plus speaker faculty as well as the other delegates and meeting’s sponsors and exhibitors.